Metraipolis › archive › dc_181a87ce2d95

Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL-2 Inhibitors — Europe PMC PMID:42830438

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42830438
DOI
10.1002/cam4.72341
License (as archived)
solo-consultazione
Archived
2026-10-07T15:57:12.628Z
SHA-256 of the archived text
9f41b0372668c5119b32e13ffb890f8c44b9110073a09a417a39baa66e8cfdc9
Stable URL of this page
https://metraipolis.com/documento/dc_181a87ce2d95

How to cite

Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL-2 Inhibitors — Europe PMC PMID:42830438 — Europe PMC (en), https://europepmc.org/article/MED/42830438 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_181a87ce2d95 (Metraipolis archive dc_181a87ce2d95, sha256 9f41b0372668c5119b32e13ffb890f8c44b9110073a09a417a39baa66e8cfdc9)
BibTeX
@misc{dc181a87ce2d95,
  title = {Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL-2 Inhibitors — Europe PMC PMID:42830438},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42830438},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_181a87ce2d95; sha256 9f41b0372668c5119b32e13ffb890f8c44b9110073a09a417a39baa66e8cfdc9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42830438. Agents can read the archived copy with the MCP tool read_document.